
Jeffrey S Miller MD
Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
516 Delaware St SESuite 5100 Clinic 5B University of Minnesota PhysiciaMinneapolis, MN 55455
Phone+1 612-273-2800
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1988
- Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
- MN State Medical License 1991 - 2025
- IA State Medical License 1985 - 1988
- IA State Medical License 1985 - 1988
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsNatural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada
Prostate Cancer and Prostatic Diseases. 2025-03-01 - 1 citationsA PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier, Rhett L Waller, Madison Shackelford
Cancer Immunology Research. 2025-02-03 - Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.John R Lozada, Andrew Elliott, Mark G Evans, James Wacker, Kathleen M Storey
Cancer Research Communications. 2025-02-01
Journal Articles
- Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source,Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel, Haematologica
- Phase I Trial of ALT-803, a Novel Recombinant Interleukin-15 Complex, in PatientsJeffrey S Miller, Shernan G Holtan, Sylvia M Lee, Chihiro Morishima, Ann, Clinical Cancer Research
Abstracts/Posters
- Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic NaturalJeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- NK Cells Lacking CD38 Are Resistant to Oxidative Stress-Induced DeathJeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- PD-1 Is Expressed at Low Levels on All Peripheral Blood Natural Killer CellsJeffrey S. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- GT Biopharma Announces Sponsored Research Agreement with Dr. Jeffrey S. Miller of the University of MinnesotaAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: